Conference Coverage (AACR)
Attenuated Salmonella typhimurium Targets Cancer Cells
Published in Cancer Weekly, May 26th, 1997
A collaborative effort between researchers from Vion Pharmaceuticals, Connecticut, and Yale University School of Medicine, Connecticut, has resulted in several studies (see subsequent stories in this issue) regarding an attenuated form of S. typhimurium as an anticancer agent. L.M. Zheng, representing colleagues from both institutions, presented evidence American Association for Cancer Research conference, held April 12-16, 1997, in San Diego, California that S. typhimurium infection inhibits tumor metastasis in vivo.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-05-26)
More Articles from Cancer Weekly
- Conference Coverage (AACR)
Salmonella typhimurium Scrutinized as Anticancer Vector - Conference Coverage (AACR)
Antisense Therapy Targets Cancer Angiogenesis - Conference Coverage (AACR)
Phase I Trial of GD3-Lactone-KLH Melanoma Vaccine Presented - Conference Coverage (AACR)
Tri-Partner Protocol Enhances Vaccine Antitumor Immunity - Conference Coverage (AACR)
Tumor Amplified Protein Expression Therapy with Salmonella Vector - Conference Coverage (Blood Safety)
Researcher Calls for Cancer Screening of Donated Blood and Organs - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
